Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Identification of a Primary Target of Thalidomide Teratogenicity
2010 StandoutScience
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Modified DNA Aptamer That Binds the ( R )-Isomer of a Thalidomide Derivative with High Enantioselectivity
2007
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation
2003
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Cytogenetics in acute leukemia
2003
Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients
2002
2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines
2000
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation
2004
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias
2006 Standout
A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias
2002
A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
2020 StandoutNobel
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Glucocorticoids and invasive fungal infections
2003
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Inflammatory Bowel Disease
2002 Standout
Graft-versus-host disease
2009 Standout
Echinocandin antifungal drugs
2003 Standout
Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?
2007
Circos: An information aesthetic for comparative genomics
2009 Standout
Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma
2006
Hematopoietic Stem-Cell Transplantation
2006 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
2001
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Understanding and harnessing the graft‐versus‐leukaemia effect
2008
Bone Marrow Transplantation
1994
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.
1994
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease
1999
Outcomes of transplantation with matched-sibling and unrelateddonor bone marrow in children with leukaemia
1997
Survival and Prognostic Factors of Invasive Aspergillosis After Allogeneic Bone Marrow Transplantation
1999
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG‐9500)
2007
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
A review of autologous hematopoietic cell transplantation
2000 Nobel
Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital
2002
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
2004
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Invasive Mold Infections in Allogeneic Bone Marrow Transplant Recipients
2001
Towards a targeted, risk‐based, antifungal strategy in neutropenic patients
2000
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Cyclosporine-Induced Hypertension After Transplantation
1994
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
The thalidomide saga
2007
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Functional Nucleic Acid Sensors
2009 Standout
IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation
2003
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Induction Of Kidney Allograft Tolerance After Transient Lymphohematopoietic Chimerism In Patients With Multiple Myeloma And End-Stage Renal Disease1
2002
A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation
2005
Intravenous and Oral Itraconazole versus Intravenous and Oral Fluconazole for Long-Term Antifungal Prophylaxis in Allogeneic Hematopoietic Stem-Cell Transplant Recipients: A Multicenter, Randomized Trial
2003
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development
2011
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
2006 Standout
Graft-versus-leukemia effects of transplantation and donor lymphocytes
2008
Cytokine Storm
2020 Standout
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
1998
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors
2000
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Chimeric Antigen Receptor Therapy
2018 Standout
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Aspergillus fumigatusand Aspergillosis
1999 Standout
Treatment of Primary Progressive Hodgkin’s and Aggressive Non-Hodgkin’s Lymphoma: Is There a Chance for Cure?
2000
The biology and treatment of acute lymphoblastic leukemia in adults
1995
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
1998
GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease
2004 StandoutNobel
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Hodgkin's lymphoma
2003
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells
2011
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Cytokine-induced radiation protection and sensitization
1996
Works of PM Parker being referenced
Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease.
1991
High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
1994
Donor leukocyte infusions in acute lymphocytic leukemia
2000
Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission
1999
Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients.
1994
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission
2000
Bone marrow transplantation for patients with Philadelphia chromosome- positive acute lymphoblastic leukemia
1987
The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone
1995
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission
1991
Thalidomide as salvage therapy for chronic graft-versus-host disease
1995
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase
1994
Bone marrow transplantation for patients with Philadelphia chromosome- positive acute lymphoblastic leukemia
1987
High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors
1995